CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Genitourinary Cancer » Prostate Cancer

RESEARCH REPORT 

ADT for Prostate Cancer Linked to Increased Risk for Biliary Disease

By Leah Lawrence | March 6, 2013

Men being treated for their prostate cancer with a gonadotropin-releasing hormone (GnRH) had a significantly increased risk for biliary disease compared with men who underwent no treatment, according to the results of a large, population-based study published in European Urology.

Space-filling model of gonadotropin-releasing hormone Space-filling model of gonadotropin-releasing hormone.

Of the 183,842 men aged 65 years or older with locoregional prostate cancer examined in the study, just under half had undergone androgen deprivation therapy (ADT) with a GnRH. At the end of study follow-up in 2009, 7.5% of men had developed biliary disease.

“ADT for prostate cancer causes a number of metabolic problems that are known to be risk factors for biliary disease in the general population,” Philip J. Saylor, MD, from the division of hematology and oncology, Massachusetts General Hospital, Boston. “The most prominent of these are obesity, in general, increased abdominal girth, in particular, elevated triglycerides, and insulin resistance.”

Saylor and colleagues found that men who did not undergo ADT had 13.4 cases of biliary disease per 1,000 person years compared with 15.7 cases for men on a GnRH (P < .001). This translated into one case of biliary disease per 435 men treated with a GnRH for a year, the researchers wrote.

“The magnitude of the increase was small but was notable for the facts that (a) most of these new diagnoses led to biliary procedures, and (b) the risk seemed to rise with increasing duration of androgen deprivation,” said Saylor.

Of the total study population, 6.8% of men had to undergo a procedure to treat the biliary disease. In addition, a statistically significant increased risk for biliary disease was found for use of a GnRH for 7 months or longer (7-12 months: HR = 1.07, P = .02; 13-24 months: HR = 1.15, P < .001; 25 or more: HR = 1.20, P < .001).

According to the researchers, the findings of the study would be best used as a renewed call to optimize the metabolic health of men receiving systemic therapy for prostate cancer.

“We should reserve therapy for the men who are most likely to benefit, and we should enthusiastically pursue healthy diet and lifestyle choices among men who need it,” Saylor said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
May 20, 2013
New AUA Guidelines for Prostate Cancer Screening
May 17, 2013
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
May 17, 2013
Radium-223 Gets Early FDA Nod for Bone Mets in Castration-Resistant Prostate Cancer
May 16, 2013
Rising PSA Level in a 46-Year-Old Man
ONCOLOGY,  May 15, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Prostate Cancer
Evidence on Prostate Cancer
Guidelines on Prostate Cancer
Patient Education on Prostate Cancer
Clinical Trials on Prostate Cancer
Practical Articles on Prostate Cancer
Research and Reviews on Prostate Cancer
All "Prostate Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy